Nymox Pharmaceutical Corporation (NYMXF)
USD 0.1
(23.3%)
USD 0.1
(23.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.05 Million | -5.2 Million | -9.82 Million | -10.03 Million | -7.43 Million | -7.8 Million |
| Net Income | -8.84 Million | -6.57 Million | -12.53 Million | -11.73 Million | -13.16 Million | -10.59 Million |
| Depreciation & Amortization | 169 Thousand | 12 Thousand | 12 Thousand | 9000.00 | 9000.00 | 3041.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.35 Million | 593 Thousand | 2.6 Million | 1.74 Million | 3.01 Million | - |
| Change in working capital | 821 Thousand | 495 Thousand | -140 Thousand | -314 Thousand | 826 Thousand | -1.12 Million |
| Other non-cash items | 440 Thousand | 509 Thousand | 3.02 Million | 2.2 Million | 4.08 Million | 5.02 Million |
| Investing Cash Flow | -3000.00 | - | -6000.00 | -13 Thousand | - | -36 Thousand |
| Investments in PPE | -3000.00 | - | -6000.00 | -13 Thousand | - | -36 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.72 Million | 5.77 Million | 7.04 Million | 8.42 Million | 4.72 Million | 14.93 Million |
| Debt repayment | -1.57 Million | -229 Thousand | -238 Thousand | -265 Thousand | -277 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.15 Million | 6 Million | 7.28 Million | 8.68 Million | 5 Million | 14.93 Million |
| Other Financing Activities | -173 Thousand | - | - | - | - | - |
| Accounts receivables | -1000.00 | 3000.00 | 7000.00 | -1000.00 | -4000.00 | 73 Thousand |
| Accounts payables | - | 376 Thousand | -165 Thousand | -172 Thousand | 819 Thousand | -1.15 Million |
| Inventory | - | - | - | -11 Thousand | 17 Thousand | -25 Thousand |
| Other working capital | 822 Thousand | 116 Thousand | 18 Thousand | -130 Thousand | -6000.00 | -17 Thousand |
| Cash at beginning of period | -1.4 Million | 830 Thousand | 3.61 Million | 5.23 Million | 7.94 Million | 851 Thousand |
| Cash at end of period | -70 Thousand | 1.4 Million | 830 Thousand | 3.61 Million | 5.23 Million | 7.94 Million |
| Capital Expenditure | -3000.00 | - | -6000.00 | -13 Thousand | - | -36 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.33 Million | 573 Thousand | -2.78 Million | -1.62 Million | -2.7 Million | 7.09 Million |
| Free Cash Flow | -4.06 Million | -5.2 Million | -9.82 Million | -10.05 Million | -7.43 Million | -7.83 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.31 Million | -8.84 Million | -1.03 Million | -1.11 Million | -1.38 Million | -6.57 Million |
| Depreciation & Amortization | 11 Thousand | 169 Thousand | 3000.00 | 2000.00 | 3000.00 | 12 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.24 Million | 3.35 Million | 11 Thousand | 32 Thousand | 70 Thousand | 593 Thousand |
| Change in working capital | 719 Thousand | 821 Thousand | -279.91 Thousand | 112.34 Thousand | 270 Thousand | 495 Thousand |
| Other non-cash items | 440 Thousand | 440 Thousand | 46.32 Thousand | 83.94 Thousand | -194 Thousand | 509 Thousand |
| Investing Cash Flow | 39.76 | -3000.00 | -2.01 | -10.60 | -3000.00 | - |
| Investments in PPE | 37.26 | -3000.00 | -2.01 | -10.60 | -3000.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 891 Thousand | 2.72 Million | 1.21 Million | 692.22 Thousand | -60.99 Thousand | 5.77 Million |
| Debt repayment | -1.74 Million | -1.57 Million | -752.65 Thousand | -752.65 Thousand | -61 Thousand | -229 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -850 Thousand | 1.15 Million | 2 Million | - | - | 6 Million |
| Other Financing Activities | -6744.76 | - | - | - | - | - |
| Accounts receivables | -4000.00 | - | 3012.62 | - | - | 3000.00 |
| Accounts payables | - | - | - | - | 326 Thousand | 376 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 723 Thousand | - | -282.93 Thousand | 27.9 Thousand | -56 Thousand | 116 Thousand |
| Cash at beginning of period | 76 Thousand | -1.4 Million | 132 Thousand | 351 Thousand | 1.4 Million | 830 Thousand |
| Cash at end of period | -70 Thousand | -70 Thousand | 76 Thousand | 132 Thousand | 351 Thousand | 1.4 Million |
| Capital Expenditure | 37.26 | -3000.00 | -2.01 | -10.60 | -3000.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -146 Thousand | 1.33 Million | -56 Thousand | -219 Thousand | -1.05 Million | 573 Thousand |
| Free Cash Flow | -896.96 Thousand | -4.06 Million | -1.26 Million | -915.71 Thousand | -991 Thousand | -5.2 Million |
003030
4132
ATLPF
6195
005010
PINF